Health policy and cost-effectiveness analysis: yes we can. Yes we must.
Wong
John B
JB
Mulrow
Cynthia
C
Sox
Harold C
HC
D003327:Coronary Disease / Q000517:prevention & control; D003362:Cost-Benefit Analysis; D006291:Health Policy / Q000191:economics*; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics; D011322:Primary Prevention / Q000191:economics; D014481:United States
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors